<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04115085</url>
  </required_header>
  <id_info>
    <org_study_id>SUR</org_study_id>
    <nct_id>NCT04115085</nct_id>
  </id_info>
  <brief_title>Study of Medical Ultrasound for Rhizarthrosis</brief_title>
  <official_title>Study of Medical Ultrasound for Rhizarthrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Waldfriede Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Waldfriede Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It was never investigated which preservative non-invasive treatments are superior to treat
      rhizarthrosis. This randomized study compares the effect of 1. hand therapy vs. 2.
      therapeutic ultrasound vs. 3. hand therapy plus therapeutic ultrasound in the treatment of
      rhizarthrosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 7, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disabilities of the Arm, Shoulder and Hand (DASH)</measure>
    <time_frame>Change after 9 weeks and 3, 4 and 8 months</time_frame>
    <description>Disabilities as measured by the DASH scale; No Difficulty (1), Mild Difficulty (2), Moderate Difficulty (3), Severe Difficulty (4), Unable (5)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale (VAS) pain</measure>
    <time_frame>Change after 9 weeks and 3, 4 and 8 months</time_frame>
    <description>From 0mm (no pain) to 100mm (maximum pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Form 36 SF-36</measure>
    <time_frame>Change after 9 weeks and 3, 4 and 8 months</time_frame>
    <description>Scored review of health questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional assessment: Thumb force</measure>
    <time_frame>Change after 9 weeks and 3, 4 and 8 months</time_frame>
    <description>Key pinch force measure of the thumb as measured in Kg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional assessment: Goniometry</measure>
    <time_frame>Change after 9 weeks and 3, 4 and 8 months</time_frame>
    <description>Measurement of the angle between the dorsal axis of the thumb and the index finger with a goniometer.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Rhizarthrosis</condition>
  <arm_group>
    <arm_group_label>Hand therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>9 weeks of standard hand therapy including two 20 min slots per week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapeutic ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>9 weeks of standard ultra sound therapy including two 10 min slots per week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined hand therapy and therapeutic ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>9 weeks of standard hand therapy plus therapeutic ultrasound including two 30 min slots per week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hand therapy (18 treatments)</intervention_name>
    <description>18 treatments (ea. 20 Min) within 9 weeks</description>
    <arm_group_label>Hand therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Therapeutic ultrasound (18 treatments)</intervention_name>
    <description>18 treatments (ea. 10 Min) within 9 weeks</description>
    <arm_group_label>Therapeutic ultrasound</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combined hand therapy and therapeutic ultrasound (18 treatments)</intervention_name>
    <description>18 treatments (ea. 30 Min) within 9 weeks</description>
    <arm_group_label>Combined hand therapy and therapeutic ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients aged 40 to 90 years

          -  Pain intensity in the region of the thumb base in pain phases ≥ 40 mm on the VAS of 0
             to 100 mm (relative to the last 24 hours)

          -  Complaints for at least 3 months

          -  X-ray Stadium Eaton I-IV at least once secured

        Exclusion Criteria:

          -  History of surgery on the affected hand, wrist or forearm

          -  Planned surgery in the next 8 months

          -  Anticoagulation (Marcumar, Heparin)

          -  Haemophilia, V. Willebrandt Jürgens syndrome, thrombocytopathy and other blood
             anomalies

          -  acute pain medication (&lt;7 days)

          -  Systemic medication with corticoids or immunosuppressants

          -  Intraarterticular injections or RSO within the last 3 months

          -  Pregnancy, lactation

          -  Insulin-dependent type I diabetes mellitus

          -  Significant cognitive impairment

          -  clinically relevant or progressive disease (e.g., liver, kidney, cardiovascular
             system, respiratory tract, vascular system, brain, metabolism, thyroid) that could
             affect the course of the study

          -  Malignant disease

          -  Simultaneous participation in an interventional study or participation in an
             interventional study in the last two months before study inclusion

          -  Clinically relevant addiction or substance abuse disorder (defined as alcohol, drug
             and drug abuse)

          -  Insufficient mental possibility of cooperation

          -  Therapy with oral anticoagulants (e.g., Marcumar)

          -  Suspected lack of compliance

          -  Medical, psychiatric or other conditions that restrict the patient's following
             abilities: to interpret the study information, to give informed consent, to adhere to
             the rules of the protocol, or to complete the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus Bock, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Waldfriede Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Lautenbach, Dr. med.</last_name>
    <role>Study Chair</role>
    <affiliation>Waldfriede Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Markus Bock, Dr. med.</last_name>
    <phone>00493081810201</phone>
    <email>m.bock@waldfriede.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Waldfriede Hospital</name>
      <address>
        <city>Berlin</city>
        <zip>14163</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Bock, Dr. med.</last_name>
      <phone>00493081810201</phone>
      <email>m.bock@waldfriede.de</email>
    </contact>
    <contact_backup>
      <last_name>Martin Lautenbach, Dr. med.</last_name>
      <phone>00493081810201</phone>
      <email>m.lautenbach@waldfriede.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>September 30, 2019</study_first_submitted>
  <study_first_submitted_qc>October 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2019</study_first_posted>
  <last_update_submitted>November 12, 2019</last_update_submitted>
  <last_update_submitted_qc>November 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Degeneration</keyword>
  <keyword>Trapeziometacarpal osteoarthritis</keyword>
  <keyword>Basal Joint Arthritis</keyword>
  <keyword>Arthrosis</keyword>
  <keyword>Hand</keyword>
  <keyword>Thumb</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

